Haleon plc Announces EMTN Bond Offering
Ticker: HLNCF · Form: 6-K · Filed: Sep 12, 2024 · CIK: 1900304
Sentiment: neutral
Topics: debt-offering, financing, emtn
TL;DR
Haleon is issuing new bonds to raise cash, details to follow.
AI Summary
Haleon plc announced an offering of senior unsecured notes under its Euro Medium Term Note (EMTN) programme on September 12, 2024. The company is offering notes in various currencies and maturities, with pricing details to be announced later. This offering is part of Haleon's ongoing financing activities.
Why It Matters
This bond offering indicates Haleon's strategy to raise capital, which could be used for general corporate purposes, debt repayment, or future investments, impacting its financial structure and potentially its credit rating.
Risk Assessment
Risk Level: low — This is a routine financing announcement and does not inherently present new risks to the company.
Key Players & Entities
- Haleon plc (company) — Issuer of the notes
- DRVW 2022 Ltd (company) — Former name of Haleon plc
- September 12, 2024 (date) — Date of the announcement and offering
FAQ
What is the purpose of the EMTN bond offering?
The filing states the offering is under Haleon plc's Euro Medium Term Note (EMTN) programme, typically used for general corporate purposes, though specific use of proceeds is not detailed in this announcement.
When was the bond offering announced?
The announcement regarding the EMTN bond offering was made on September 12, 2024.
What is the filing form type?
The filing form type is a 6-K, which is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What was Haleon plc's former name?
Haleon plc's former name was DRVW 2022 Ltd, with a date of name change on December 17, 2021.
Where is Haleon plc's principal executive office located?
Haleon plc's principal executive offices are located at Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY.
Filing Stats: 635 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2024-09-12 06:16:37
Key Financial Figures
- $1.75b — oses including partial repayment of the $1.75bn bond maturing in March 2025.  
Filing Documents
- a8577d.htm (6-K) — 29KB
- 0001654954-24-011770.txt ( ) — 31KB
From the Filing
PLC: EMTN BOND OFFERING a8577d   UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of September 2024   Commission File Number: 001-41411   Haleon plc (Translation of registrant’s name into English)   Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices)     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:     Form 20-F ☒   Form 40-F ☐       EXHIBIT INDEX   Exhibit Number Description 99.1  12 September 2024 - “Haleon plc: EMTN bond offering”   99.1   Haleon plc: EMTN bond offering   12 September 2024:   Haleon plc (the "Company" or “Haleon”) (LSE/NYSE: HLN) today announces that, on 11 September 2024, its wholly-owned subsidiary, Haleon UK Capital plc, successfully priced two notes under its Euro Medium Term Note (“EMTN”) programme (the “Offering”). The Offering is expected to close on 18 September 2024, subject to customary closing conditions.   The Offering consisted of the following notes, issued by Haleon UK Capital plc and fully and unconditionally guaranteed by the Company:   ● €750,000,000 of fixed rate notes with a coupon of 2.875% maturing on 18 September 2028; and   ● £300,000,000 of fixed rate notes with a coupon of 4.625% maturing on 18 September 2033 (together, the “Notes”)   The Company expects to use the net proceeds of the Offering for general corporate purposes including partial repayment of the $1.75bn bond maturing in March 2025.   Barclays, Bank of America, BNP Paribas and JP Morgan acted as joint book-running managers on the transaction.   The Notes will be issued under Haleon UK Capital plc’s and Haleon Netherlands Capital B.V.’s £10,000,000,000 EMTN programme and admitted to trading on the International Securities Market of the London Stock Exchange.   The Notes have not been registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration.   This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the Notes described herein, nor shall there be any sale of these Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.     Amanda Mellor   Company Secretary       Enquiries   Investors Media Sonya Ghobrial +44 7392 784784 Zoë Bird +44 7736 746167 Rakesh Patel +44 7552 484646 Gemma Thomas +44 7985 175048 Emma White +44 7823 523562       Email: investor-relations@haleon.com   Email: corporate.media@haleon.com   About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.   For more information, please visit   www.haleon.com .                                                SIGNATURE       Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       HALEON PLC (Registrant)   Date: September 12, 2024 By: /s/ Amanda Mellor     Name: Amanda Mellor     Title: Company Secretary